Seer, Inc. (SEER) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
Despite a strong 30% YoY revenue growth and improved gross margins, the net loss widened due to increased operating expenses, raising concerns. The absence of strategic initiative updates and the emphasis on risks in forward-looking statements further contribute to uncertainty. Without clear guidance or significant positive catalysts, a neutral stock price movement is likely in the next two weeks.
Key Financial Performance
Revenue Seer reported revenue of $5.2 million for Q1 2026, representing a 30% increase year-over-year. This growth was driven by increased adoption of the company's Proteograph Product Suite.
Net Loss The net loss for Q1 2026 was $12.8 million, compared to $10.5 million in Q1 2025. The increase in net loss was attributed to higher operating expenses, including investments in R&D and commercial infrastructure.
Gross Margin Gross margin for Q1 2026 was 65%, up from 60% in Q1 2025. The improvement was due to better cost efficiencies and higher revenue contribution from the Proteograph Product Suite.
Operating Expenses Operating expenses for Q1 2026 were $18.5 million, up from $15 million in Q1 2025. The increase was primarily due to expanded R&D efforts and scaling of commercial operations.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements: Management highlighted that forward-looking statements involve material risks and uncertainties that could cause actual results or events to differ materially from expectations. This indicates potential challenges in achieving projected outcomes.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Boucher TD
CEO Chair
CFO Kyle
Canaccord Genuity
Chair Directors
Conference Instructions
Corp Research
Cowen Research
Directors President
Division Kyle
Division day
EDT Omid
Farokhzad Founder
Form filing
Founder CEO
Genuity Corp
Gilmartin Group
Group statement
Instructions event
Kyle Boucher
Kyle Mikson
Mikson Canaccord
Omid Farokhzad
PM EDT
President Treasurer
Research Division
Treasurer CFO
conference Gilmartin
day Conference
SEER Transcript
Seer, Inc. (SEER) Q1 2026 Earnings Call Transcript
Unknown5-13
Despite a strong 30% YoY revenue growth and improved gross margins, the net loss widened due to increased operating expenses, raising concerns. The absence of strategic initiative updates and the emphasis on risks in forward-looking statements further contribute to uncertainty. Without clear guidance or significant positive catalysts, a neutral stock price movement is likely in the next two weeks.
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Positive2-26
The earnings call highlights strong revenue growth, improved gross margins, and reduced net loss, suggesting positive financial performance. The company's strategic initiatives, including expanded partnerships and increased R&D investments, further bolster future growth prospects. Although macroeconomic pressures and potential government shutdown impacts are noted, the overall sentiment remains optimistic, driven by strong demand and innovation in core markets.
Seer, Inc. (SEER) Q3 2025 Earnings Call Transcript
Unknown11-6
The earnings call presents a mixed outlook. The partnership with Thermo Fisher and new product launches are positive, but macroeconomic headwinds and uncertainties in government funding pose risks. The financial performance shows modest revenue growth and a reduced net loss, but free cash flow loss remains significant. The share repurchase program is a positive signal, but concerns about academic spending persist. Overall, the sentiment is neutral due to balanced positive and negative factors, with no decisive catalyst to drive strong stock movement.
Seer, Inc. (SEER) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Neutral9-9
SEER Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
